Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhieddine Labban

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
European Urology Oncology|December 28, 2023
The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer MortalityBenjamin V Stone, Muhieddine Labban, Edoardo Beatrici, et al.
JAMA Network Open|July 27, 2023
Disparities in Travel-Related Barriers to Accessing Health Care From the 2017 National Household Travel SurveyMuhieddine Labban, Chang-Rong Chen, Nicola Frego, et al.
Clinical Genitourinary Cancer|June 14, 2023
The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United StatesBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urology|October 24, 2024
Trends and Safety of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Comparison Between the Pre-pandemic and Pandemic Periods From the National Cancer DatabaseFilippo Dagnino, Muhieddine Labban, Brittany Berk, et al.
Clinical Genitourinary Cancer|January 10, 2026
Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall SurvivalDejan K Filipas, José I Nolazco, Benjamin V Stone, et al.
JNCI Cancer Spectrum|October 6, 2023
The national utilization of nonoperative management for small renal masses over 10 yearsDejan K Filipas, Edoardo Beatrici, Jose I Nolazco, et al.
Urologic Oncology|February 9, 2023
Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populationsDavid-Dan Nguyen, Muhieddine Labban, Logan Briggs, et al.
BMC Medicine|November 6, 2025
Rising metastatic prostate cancer rates but narrowing racial gapHanna Zurl, Zhiyu Qian, Klara K Pohl, et al.
Urologic Oncology|October 15, 2024
Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance systemFilippo Dagnino, Zhiyu Qian, Muhieddine Labban, et al.
European Urology Open Science|May 30, 2024
Urinary and Sexual Impact of Robotic Radical Prostatectomy: Reporting of Patient-reported Outcome Measures in the First Year after Radical Prostatectomy in a Contemporary Multicentre Cohort in the United KingdomJoshua Bridge, Muhieddine Labban, Alexander P Cole, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
European Urology Oncology|December 28, 2023
The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer MortalityBenjamin V Stone, Muhieddine Labban, Edoardo Beatrici, et al.
JAMA Network Open|July 27, 2023
Disparities in Travel-Related Barriers to Accessing Health Care From the 2017 National Household Travel SurveyMuhieddine Labban, Chang-Rong Chen, Nicola Frego, et al.
Clinical Genitourinary Cancer|June 14, 2023
The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United StatesBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urology|October 24, 2024
Trends and Safety of Same-day Discharge for Robot-assisted Laparoscopic Prostatectomy: A Comparison Between the Pre-pandemic and Pandemic Periods From the National Cancer DatabaseFilippo Dagnino, Muhieddine Labban, Brittany Berk, et al.
Clinical Genitourinary Cancer|January 10, 2026
Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall SurvivalDejan K Filipas, José I Nolazco, Benjamin V Stone, et al.
JNCI Cancer Spectrum|October 6, 2023
The national utilization of nonoperative management for small renal masses over 10 yearsDejan K Filipas, Edoardo Beatrici, Jose I Nolazco, et al.
Urologic Oncology|February 9, 2023
Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populationsDavid-Dan Nguyen, Muhieddine Labban, Logan Briggs, et al.
BMC Medicine|November 6, 2025
Rising metastatic prostate cancer rates but narrowing racial gapHanna Zurl, Zhiyu Qian, Klara K Pohl, et al.
Urologic Oncology|October 15, 2024
Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance systemFilippo Dagnino, Zhiyu Qian, Muhieddine Labban, et al.
European Urology Open Science|May 30, 2024
Urinary and Sexual Impact of Robotic Radical Prostatectomy: Reporting of Patient-reported Outcome Measures in the First Year after Radical Prostatectomy in a Contemporary Multicentre Cohort in the United KingdomJoshua Bridge, Muhieddine Labban, Alexander P Cole, et al.
Pageof 8